Colorectal liver metastases: An update on palliative treatment options

Journal of Gastrointestinal and Liver Diseases

Volumn 21, Issue 1, 2012, Pages 83-91

  Konopke, Ralf ^a   Roth, Johanna ^a   Volk, Andreas ^a   Pistorius, Steffen ^a   Folprecht, Gunnar ^b   Zoephel, Klaus ^b   Schuetze, Christina ^a   Laniado, Michael ^c   Saeger, Hans Detlev ^a   Kersting, Stephan ^a  

^a Thoracic and Vascular Surgery ^*  (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Colorectal cancer; Liver metastasis; Palliative treatment

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; GELFOAM; IODINATED POPPYSEED OIL; IRINOTECAN; OXALIPLATIN; PANITUMUMAB; POLYVINYL ALCOHOL SPONGE; STARCH MICROSPHERE; YTTRIUM 90;

ARTERIOBILIARY FISTULA; ARTERY THROMBOSIS; BILE DUCT FISTULA; BILE DUCT INJURY; BILE LEAKAGE; BILIARY TRACT INFECTION; BLAND VASCULAR EMBOLIZATION; BLOOD VESSEL INJURY; BRACHYTHERAPY; BRADYCARDIA; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CATHETER COMPLICATION; CHEMOEMBOLIZATION; CHOLANGITIS; CHOLECYSTITIS; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; COMPUTER ASSISTED RADIOTHERAPY; CRYOSURGERY; CRYOTHERAPY; DIARRHEA; DIGESTIVE SYSTEM PERFORATION; DRUG DELIVERY SYSTEM; DRUG ELUTING BEAD; FEVER; GASTRODUODENAL ULCER; GASTROENTERITIS; GASTROINTESTINAL HEMORRHAGE; HEMOBILIA; HEMOPERITONEUM; HIGH FREQUENCY FOCUSED ULTRASOUND; HUMAN; HYPERTENSION; HYPERTRANSAMINASEMIA; INOPERABLE CANCER; INTENSITY MODULATED RADIATION THERAPY; ION THERAPY; KIDNEY FAILURE; LASER THERMOTHERAPY; LIVER ABSCESS; LIVER FAILURE; LIVER HEMATOMA; LIVER METASTASIS; LUNG EMBOLISM; MICROWAVE THERAPY; NEUROTOXICITY; PAIN; PLEURA EFFUSION; PNEUMONIA; PNEUMOTHORAX; PROTEINURIA; PROTON THERAPY; QUALITY OF LIFE; RADIATION INDUCED LIVER DISEASE; RADIATION INJURY; RADIATION NECROSIS; RADIOFREQUENCY ABLATION; REVIEW; SELECTIVE INTERNAL RADIOTHERAPY; STEREOTACTIC BODY RADIATION THERAPY; SYSTEMIC THERAPY; TUMOR LYSIS SYNDROME; ULTRASOUND THERAPY; VOMITING; WHOLE LIVER RADIATION THERAPY; WOUND HEALING IMPAIRMENT;

COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; LIVER NEOPLASMS; PALLIATIVE CARE;

EID: 84858855821     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-592.
2. Ruers T, Bleichrodt RP. Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 2002;38:1023-1033.
3. Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 1969;23:198-202.
4. Chun YS, Vauthey JN. Extending the frontiers of resectability in advanced colorectal cancer. Eur J Surg Oncol 2007;33 Suppl 2: S52-S58.
5. Giacchetti S, Perpoint B, Zidani R, et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fuorouracil-leucovorin as frst-line treatment of metastatic colorectal cancer. J Clin Oncol 2000;18:136-147.
6. Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fuorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000;343:905-914.
7. de Gramont A, Figer A, Seymour M, et al. Leucovorin and fuorouracil with or without oxaliplatin as frst-line treatment in advanced colorectal cancer. J Clin Oncol 2000;18:2938-2947.
8. Rougier P, Lepille D, Bennouna J, et al. Antitumour activity of three second-line treatment combinations in patients with metastatic colorectal cancer after optimal 5-FU regimen failure: a randomised, multicentre phase II study. Ann Oncol 2002;13:1558-1567.
9. Reinacher-Schick A. Systemic treatment of advanced colorectal cancer. Pathologe 2008;29 Suppl 2:191-195.
10. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fuorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-2342.
11. Karapetis CS, Khambata-Ford S, Jonker DJ, et al. K-ras mutations and beneft from cetuximab in advanced colorectal cancer. N Engl J Med 2008;359:1757-1765.
12. Van Cutsem E, Köhne CH, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 2009;360:1408-1417.
13. Saltz LB, Clarke S, Díaz-Rubio E, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 2008;26:2013-2019.
14. Giantonio BJ, Catalano PJ, Meropol NJ, et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 2007;25:1539-1544.
15. Yamane B, Weber S. Liver-directed treatment modalities for primary and secondary hepatic tumors. Surg Clin North Am 2009;89:97-113.
16. Liapi E, Geschwind JF. Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol 2007;25:978-986.
17. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003;226:441-451.
18. Feliberti EC, Wagman LD. Radiofrequency ablation of liver metastases from colorectal carcinoma. Cancer Control 2006;13:48-51.
19. Mulier S, Mulier P, Ni Y, et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002;89:1206-1222.
20. de Baere T, Elias D, Dromain C, et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol 2000;175:1619-1625.
21. Solbiati L, Livraghi T, Goldberg SN, et al Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001;221:159-166.
22. Sorensen SM, Mortensen F V, Nielsen DT. Radiofrequency ablation of colorectal liver metastases: long-term survival. Acta Radiol 2007;48:253-258.
23. Kainuma O, Asano T, Aoyama H, et al. Combined therapy with radiofrequency thermal ablation and intra-arterial infusion chemotherapy for hepatic metastases from colorectal cancer. Hepatogastroenterology 1999;46:1071-1077.
24. Machi J, Oishi AJ, Sumida K, et al. Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in frst- and second-line management. Cancer J 2006;12:318-326.
25. Ritz JP, Lehmann KS, Zurbuchen U, et al. Improving laser-induced thermotherapy of liver metastases--effects of arterial microembolization and complete blood fow occlusion. Eur J Surg Oncol 2007;33:608-615.
26. Mack MG, Straub R, Eichler K, et al. Percutaneous MR imaging-guided laser-induced thermotherapy of hepatic metastases. Abdom Imaging 2001;26:369-374.
27. Helmberger TK, Roth U, Empen K. Massive air embolism during interventional laser therapy of the liver: successful resuscitation without chest compression. Cardiovasc Intervent Radiol 2002;25:335-336.
28. Vogl T, Mack M, Straub R, et al. Thermal ablation of liver metastases. Current status and prospects. Radiologe 2001;41:49-55.
29. Vogl TJ, Muller PK, Mack MG, Straub R, Engelmann K, Neuhaus P. Liver metastases: interventional therapeutic techniques and results, state of the art. Eur Radiol 1999;9:675-684.
30. Eickmeyer F, Schwarzmaier HJ, Muller FP, Nakic Z, Yang Q, Fiedler V. Survival after laser-induced interstitial thermotherapy of colorectal liver metastases--a comparison of frst clinical experiences with current therapy results. Rofo 2008;180:35-41.
31. Strickland AD, Clegg PJ, Cronin NJ, et al. Experimental study of large-volume microwave ablation in the liver. Br J Surg 2002;89:1003-1007.
32. Liang P, Wang Y. Microwave ablation of hepatocellular carcinoma. Oncology 2007;72 Suppl 1:124-131.
33. Zhang X, Zhou L, Chen B, Hu S, Wachtel MS, Frezza EE. Microwave ablation with cooled-tip electrode for liver cancer: an analysis of 160 cases. Minim Invasive Ther Allied Technol 2008;17:303-307.
34. Zhou P, Liang P, Yu X, Wang Y, Dong B. Percutaneous microwave ablation of liver cancer adjacent to the gastrointestinal tract. J Gastrointest Surg 2009;13:318-324.
35. Liang P, Dong BW, Yu XL, et al. Evaluation of long-term therapeutic effects of ultrasound-guided percutaneous microwave ablation of liver metastases. Zhonghua Yi Xue Za Zhi 2006;86:806-810.
36. Morita T, Shibata T, Okuyama M, et al. Microwave coagulation therapy for liver metastases from colorectal cancer. Gan To Kagaku Ryoho 2004;31:695-699.
37. Flanders VL, Gervais DA. Ablation of liver metastases: current status. J Vasc Interv Radiol;21:S214-222.
38. Shono Y, Tabuse K, Tsuji T, et al. Microwave coagulation therapy for unresectable colorectal metastatic liver tumor. Gan To Kagaku Ryoho 2002;29:856-859.
39. Grundmann RT, Hermanek P, Merkel S, etal. Diagnosis and treatment of colorectal liver metastases - workfow. Zentralbl Chir 2008;133:267-284.
40. Yagel S. High-intensity focused ultrasound: a revolution in non-invasive ultrasound treatment? Ultrasound Obstet Gynecol 2004;23:216-217.
41. Illing RO, Kennedy JE, Wu F, et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer 2005;93:890-895.
42. Dubinsky TJ, Cuevas C, Dighe MK, Kolokythas O, Hwang JH. High-intensity focused ultrasound: current potential and oncologic applications. AJR Am J Roentgenol 2008;190:191-199.
43. Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer 2005;5:321-327.
44. Gignoux BM, Ducerf C, Mabrut JY, Rivoire M, Rode A, Baulieux J. Cryosurgery of primary and metastatic cancers of the liver. Ann Chir 2001;126:950-959.
45. Sotsky TK, Ravikumar TS. Cryotherapy in the treatment of liver metastases from colorectal cancer. Semin Oncol 2002;29:183-191.
46. Seifert JK, Junginger T, Morris DL. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb 1998;43:141-154.
47. Paganini AM, Rotundo A, Barchetti L, Lezoche E. Cryosurgical ablation of hepatic colorectal metastases. Surg Oncol 2007;16 Suppl 1:S137-S140.
48. Ravikumar TS, Kaleya R, Ksihinevsky A. Surgical ablation therapy of liver tumors. PPO updates 2000; 14:1-12.
49. Seifert JK, Junginger T. Prognostic factors for cryotherapy of colorectal liver metastases. Eur J Surg Oncol 2004;30:34-40.
50. Chen Y Y, Perera DS, Yan TD, Schmidt LM, Morris DL. Applying Fong's CRS liver score in patients with colorectal liver metastases treated by cryotherapy. Asian J Surg 2006;29:238-241.
51. Seifert JK, Junginger T. Cryotherapy for liver tumors: current status, perspectives, clinical results, and review of literature. Technol Cancer Res Treat 2004;3:151-163.
52. Tanaka T, Arai Y, Inaba Y, et al. Radiologic placement of side-hole catheter with tip fxation for hepatic arterial infusion chemotherapy. J Vasc Interv Radiol 2003;14:63-68.
53. Irie T. Intraarterial chemotherapy of liver metastases: implantation of a microcatheter-port system with use of modifed fxed catheter tip technique. J Vasc Interv Radiol 2001;12:1215-1218.
54. Venturini M, Angeli E, Salvioni M, et al. Complications after percutaneous transaxillary implantation of a catheter for intraarterial chemotherapy of liver tumors: clinical relevance and management in 204 patients. AJR Am J Roentgenol 2004;182:1417-1426.
55. Vogl TJ, Zangos S, Eichler K, Yakoub D, Nabil M. Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update. Eur Radiol 2007;17:1025-1034.
56. Gallagher DJ, Kemeny N. Metastatic colorectal cancer: from improved survival to potential cure. Oncology 2010;78:237-248.
57. Link KH, Kornmann M, Formentini A, et al. Regional chemotherapy of non-resectable liver metastases from colorectal cancer - literature and institutional review. Langenbecks Arch Surg 1999;384:344-353.
58. Zalcberg JR, Kemeny NE. Systemic or regional chemotherapy for liver metastases from colorectal cancer: has the wheel stopped spinning? Cancer J 2004;10:271-279.
59. Kemeny N, Fata F. Arterial, portal, or systemic chemotherapy for patients with hepatic metastasis of colorectal carcinoma. J Hepatobiliary Pancreat Surg 1999;6:39-49.
60. Ducreux M, Ychou M, Laplanche A, et al. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol 2005;23:4881-4887.
61. Gallagher DJ, Capanu M, Raggio G, Kemeny N. Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis. Ann Oncol 2007;18:1995-1999.
62. Boige V, Malka D, Elias D, et al. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure. Ann Surg Oncol 2008;15:219-226.
63. Salman HS, Cynamon J, Jagust M, et al. Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver. Clin Colorectal Cancer 2002;2:173-179.
64. Lang EK, Brown CL Jr. Colorectal metastases to the liver: selective chemoembolization. Radiology 1993;189:417-422.
65. Ohtsuka Y, Matsunaga T, Yoshida H, Kouchi K, Okada T, Ohnuma N. Optimal strategy of preoperative transcatheter arterial chemoembolization for hepatoblastoma. Surg Today 2004;34:127-133.
66. Hirasawa T, Asahara S, Fujisaki S, et al. Transcatheter arterial chemoembolization (TACE) using degradable starch microspheres (DSM) for metastatic liver tumors in patients with gastric cancer. Nihon Shokakibyo Gakkai Zasshi 2008;105:367-372.
67. Fiorentini G, Rossi S, Bonechi F, et al. Intra-arterial hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II study. J Chemother 2004;16:293-297.
68. Wasser K, Giebel F, Fischbach R, Tesch H, Landwehr P. Transarterial chemoembolization of liver metastases of colorectal carcinoma using degradable starch microspheres (Spherex): personal investigations and review of the literature]. Radiologe 2005;45:633-643.
69. You YT, Changchien CR, Huang JS, Ng KK. Combining systemic chemotherapy with chemoembolization in the treatment of unresectable hepatic metastases from colorectal cancer. Int J Colorectal Dis 2006;21:33-37.
70. Popov I, Lavrnic S, Jelic S, Jezdic S, Jasovic A. Chemoembolization for liver metastases from colorectal carcinoma: risk or a beneft. Neoplasma 2002;49:43-48.
71. Fiorentini G, Aliberti C, Benea G, et al. TACE of liver metastases from colorectal cancer adopting irinotecan-eluting beads: benefcial effect of palliative intra-arterial lidocaine and post-procedure supportive therapy on the control of side effects. Hepatogastroenterology 2008;55:2077-2082.
72. Vogl TJ, Gruber T, Balzer JO, Eichler K, Hammerstingl R, Zangos S. Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study. Radiology 2009;250:281-289.
73. Kettenbach J, Stadler A, Katzler I V, et al. Drug-loaded microspheres for the treatment of liver cancer: review of current results. Cardiovasc Intervent Radiol 2008;31:468-476.
74. Aliberti C, Tilli M, Benea G, Fiorentini G. Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results. Anticancer Res 2006;26:3793-3795.
75. Martin RC, Robbins K, Tomalty D, et al. Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report. World J Surg Oncol 2009;7:80.
76. Ingold JA, Reed GB, Kaplan HS, Bagshaw MA. Radiation Hepatitis. Am J Roentgenol Radium Ther Nucl Med 1965;93:200-208.
77. Austin-Seymour MM, Chen GT, Castro JR, et al. Dose volume histogram analysis of liver radiation tolerance. Int J Radiat Oncol Biol Phys 1986;12:31-35.
78. Feyer P, Steingraber M. Strahlentherapeutische Optionen in fortgeschrittenen erkrankungssituationen. Onkologe 2007;13:590-601.
79. Leibel SA, Pajak TF, Massullo V, et al. A comparison of misonidazole sensitized radiation therapy to radiation therapy alone for the palliation of hepatic metastases: results of a Radiation Therapy Oncology Group randomized prospective trial. Int J Radiat Oncol Biol Phys 1987;13:1057-1064.
80. Bruso CE, Shewach DS, Lawrence TS. Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells. Int J Radiat Oncol Biol Phys 1990;19:1411-1417.
81. Witte RS, Cnaan A, Mansour EG, Barylak E, Harris JE, Schutt AJ. Comparison of 5-fuorouracil alone, 5-fuorouracil with levamisole, and 5-fuorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma. Cancer 2001;91:1020-1028.
82. Lee MT, Kim JJ, Dinniwell R, et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 2009;27:1585-1591.
83. Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009;27:1572-1578.
84. Goodman KA, Wiegner EA, Maturen KE, et al. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys 2010;78:486-493.
85. Dawson LA, Eccles C, Craig T. Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol 2006;45:856-864.
86. Hoyer M, Roed H, Traberg Hansen A, et al. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 2006;45:823-830.
87. Herfarth KK, Debus J, Lohr F, et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 2001;19:164-170.
88. Ricke J, Mohnike K, Pech M, et al. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2010;78:479-485.
89. Ricke J, Wust P, Stohlmann A, et al. CT-Guided brachytherapy. A novel percutaneous technique for interstitial ablation of liver metastases. Strahlenther Onkol 2004;180:274-280.
90. Pech M, Wieners G, Kryza R, et al. CT-guided brachytherapy (CTGB) versus interstitial laser ablation (ILT) of colorectal liver metastases: an intraindividual matched-pair analysis. Strahlenther Onkol 2008;184:302-306.
91. Nijsen JF, van het Schip AD, Hennink WE, Rook DW, van Rijk PP, de Klerk JM. Advances in nuclear oncology: microspheres for internal radionuclide therapy of liver tumours. Curr Med Chem 2002;9:73-82.
92. Salem R, Thurston KG. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction. J Vasc Interv Radiol 2006;17:1571-1593.
93. Lim L, Gibbs P, Yip D, et al. A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy. BMC Cancer 2005;5:132.
94. Welsh JS, Kennedy AS, Thomadsen B. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2006;66:S62-73.
95. Stuart JE, Tan B, Myerson RJ, et al. Salvage radioembolization of liver-dominant metastases with a resin-based microsphere: initial outcomes. J Vasc Interv Radiol 2008;19:1427-1433.
96. Gray B, Van Hazel G, Hope M, et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 2001;12:1711-1720.
97. Sharma RA, Van Hazel GA, Morgan B, et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fuorouracil, and leucovorin chemotherapy. J Clin Oncol 2007;25:1099-1106.
98. Van Hazel G, Blackwell A, Anderson J, et al. Randomised phase 2 trial of SIR-Spheres plus fuorouracil/leucovorin chemotherapy versus fuorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 2004;88:78-85.